Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Gastrinoma

• 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
• Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
• YF476 and Type II Gastric Carcinoids
• Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
• Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
• A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
• Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
• Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
• Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
• Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
• Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
• Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
• Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
• Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
• Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
• Treatment of Zollinger-Ellison Syndrome With Prevacid
• Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
• Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
• Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
• Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
• The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
• Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas